Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1, 2 and 4 weeks

Journal of the European Academy of Dermatology and Venereology

Volumn 11, Issue 2, 1998, Pages 141-146

  Talarico Filho, S ^a   Cuce L C ^b   Foss, N T ^b   Marques, S A ^c   Santamaria, J R ^d  

^a Servico de Dermatologia   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^d Faculdade Evangelica Med do Parana   (Brazil)

Author keywords

Antifungal agents; Child; Tinea capitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; GRISEOFULVIN; KETOCONAZOLE; TERBINAFINE;

ARTICLE; BRAZIL; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FLUORESCENCE; FOLLOW UP; FUNGUS CULTURE; GASTROINTESTINAL SYMPTOM; HUMAN; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MICROSPORUM CANIS; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TINEA CAPITIS; TRICHOPHYTON; URTICARIA;

ADMINISTRATION, ORAL; ADOLESCENT; ALKALINE PHOSPHATASE; ANOREXIA; ANTIFUNGAL AGENTS; BILIRUBIN; BRAZIL; CHILD; CHILD, PRESCHOOL; CONSTIPATION; DIARRHEA; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEADACHE; HUMANS; INFANT; MALE; MICROSPORUM; NAPHTHALENES; NAUSEA; SINGLE-BLIND METHOD; SKIN; TABLETS; TINEA CAPITIS; TREATMENT OUTCOME; TRICHOPHYTON;

EID: 7344261264     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0926-9959(98)00079-8     Document Type: Article

References (9)

1. Hay RJ, Roberts SOB, Mackenzie DWR. Mycology. In: Champion RH, Burton JL, Ebling FJG, editors. Rook, Wilkinson, Ebling Textbook of Dermatology, fifth ed. London: Blackwell Scientific Publications, 1992:1127-1216.
2. Ryder NS. Terbinafine: mode of action and properties of the squalene epoxidase inhibition. Br J Dermatol 1992;126:2-7.
3. Villars VV, Jones TC. Special features of the clinical use of oral terbinafine in the treatment of fungal diseases. Br J Dermatol 1992;126:61-69.
4. Jones TC. Overview of the use of terbinafine (Lamisil®) in children. Br J Dermatol 1995;132:683-689.
5. Haroon TS, et al. A randomized double-blind, comparative study of terbinafine vs griseofulvin in Tinea capitis. J Dermatol Treat 1992;3:25-27.
6. Alvi KH, et al., A randomized, double-blind trial of the efficacy and tolerability of terbinafine once daily compared to griseofulvin once daily in the treatment of Tinea capitis. In: Shuster S, Jafary MH, editors. Terbinafine in the treatment of superficial fungal infections. Proceedings of the Asia-Pacific Symposium on Lamisil, Series: International Congress and Symposium, No. 205. London: Royal Society of Medicine Services, 1993:35-40.
7. Balfour JA, Faulds D. Terbinafine - a review of pharmacokinetic properties, and therapeutic potential in superficial mycoses. Drugs 1992;43:259-284.
8. Minelli L., Minelli HJ. Dermatoses na infância: estudo estatístico de 6.000 casos. An bras Dermatol 1992;67:15-18.
9. Nejjam F, Zagula M, Cabiac MD, et al. Pilot study of terbinafine in children suffering from Tinea capitis: evaluation of efficacy, safety and pharmacokinetics. Br J Dermatol 1995;132:98-105.